|
0
|
|
Genetic and clinical predictors of voriconazole pharmacokinetics and hepatotoxicity: focused on CYP2C19 normal and intermediate metabolizers.
(academic.oup.com)
|
Li H
…
Bian X
Journal of Antimicrobial Chemotherapy
2026-02-02
|
#pharmacokinetics
#antifungal
#pharmacogenomics
#hepatotoxicity
|
|
0
|
|
Antifungal susceptibility surveillance of clinical moulds to olorofim, manogepix, amphotericin B, triazoles and echinocandins at 10 tertiary hospitals in China (2019-24).
(academic.oup.com)
|
Chen S
…
Liu W
Journal of Antimicrobial Chemotherapy
2026-02-02
|
#infection
#amr
#susceptibility
#surveillance
#antifungal
|
|
0
|
|
Precision dosing of systemic antifungals in adults: therapeutic drug monitoring, empiric dose optimization and barriers to implementation.
(academic.oup.com)
|
Chastain DB
…
Cluck DB
Journal of Antimicrobial Chemotherapy
2026-02-02
|
#pharmacokinetics
#dosing
#amr
#antifungal
#therapeutic drug monitoring
|
|
0
|
|
Impact of body mass index and serum albumin levels on isavuconazole plasma concentrations in patients with haematological malignancies.
(academic.oup.com)
|
Gao J
…
Yao Q
Journal of Antimicrobial Chemotherapy
2026-02-02
|
#pharmacokinetics
#antifungal
#haematological
#therapeuticdrugging
|